We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

78 hedge funds and large institutions have $516M invested in GenMark Diagnostics, Inc in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 19

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

9% more capital invested

Capital invested by funds: $474M → $516M (+$42M)

7% more funds holding

Funds holding: 73 → 78 (+5)

18% less call options, than puts

Call options by funds: $9K | Put options by funds: $11K

Holders
78
Holders Change
+5
Holders Change %
+6.85%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
35
Reduced
19
Closed
8
Calls
$9K
Puts
$11K
Net Calls
-$2K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$5.62M
2
PI
Putnam Investments
Massachusetts
+$4.42M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.94M
4
CCM
Cadian Capital Management
New York
+$3.89M
5
Ameriprise
Ameriprise
Minnesota
+$3.29M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$18.9M
2
PHS
PFM Health Sciences
California
-$7.89M
3
Citadel Advisors
Citadel Advisors
Florida
-$5.11M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.14M
5
Artisan Partners
Artisan Partners
Wisconsin
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$2.71M +$810K +66,698 +49%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.57M +$357K +29,373 +18%
GTC
28
Ghost Tree Capital
New York
$2.52M +$2.31M +190,000 New
DCM
29
Driehaus Capital Management
Illinois
$2.02M +$1.85M +152,153 New
TCIM
30
TIAA CREF Investment Management
New York
$1.87M +$62.8K +5,170 +4%
NIP
31
Nicholas Investment Partners
California
$1.69M +$1.54M +126,899 New
WMSA
32
Weiss Multi-Strategy Advisers
New York
$1.66M +$425K +35,000 +39%
FLAM
33
First Light Asset Management
Minnesota
$1.57M +$1.44M +118,338 New
Deutsche Bank
34
Deutsche Bank
Germany
$1.48M -$1.75M -143,843 -56%
BIM
35
BlackRock Investment Management
Delaware
$1.29M -$23.1K -1,902 -2%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$1.19M +$311K +25,602 +39%
MWNA
37
Marshall Wace North America
New York
$1.12M +$527K +43,413 +106%
IGIM
38
I.G. Investment Management
Manitoba, Canada
$1.07M – – –
Charles Schwab
39
Charles Schwab
California
$1.07M +$35K +2,880 +4%
CCI
40
Columbus Circle Investors
$931K -$55.4K -4,560 -6%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$863K +$8.5K +700 +1%
TA
42
Teachers Advisors
New York
$672K +$111K +9,160 +22%
TD Asset Management
43
TD Asset Management
Ontario, Canada
$640K -$313K -25,800 -35%
Morgan Stanley
44
Morgan Stanley
New York
$558K +$47.4K +3,903 +10%
HCMT
45
Highland Capital Management (Texas)
Texas
$486K -$330K -27,159 -43%
AllianceBernstein
46
AllianceBernstein
Tennessee
$478K +$152K +12,500 +53%
MLICM
47
Metropolitan Life Insurance Company (MetLife)
New York
$406K +$66.9K +5,507 +22%
NFA
48
Nationwide Fund Advisors
Ohio
$368K -$11.1K -915 -3%
Citigroup
49
Citigroup
New York
$362K +$329K +27,123 +47,584%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$361K +$15.8K +1,300 +5%
1
2
3 4

GNMK Hedge Fund Activity: Q4 2013 in Review

78 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2013, worth a combined $516M — up 8.9% from $474M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GNMK positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 19 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $5.62M. The largest seller was T. Rowe Price Associates, cutting an estimated $18.9M.

  • 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2013, up from 73 in Q3 2013.
  • Funds reported $516M of GenMark Diagnostics, Inc stock for Q4 2013, up 8.9% quarter-over-quarter.
  • 13 funds opened new GenMark Diagnostics, Inc positions in Q4 2013 and 8 closed out, a net change of +5 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2013 was JP Morgan Chase, an estimated $5.62M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2013 was T. Rowe Price Associates, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2013.